What is United Therapeutics Corp's Market Cap?

United Therapeutics Corp's Market Cap is $23.6B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Enterprise Value?

United Therapeutics Corp's Enterprise Value is $20.9B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Trailing P/E?

United Therapeutics Corp's Trailing P/E is 18.0×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Price / Sales?

United Therapeutics Corp's Price / Sales is 7.5×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EV / Revenue?

United Therapeutics Corp's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EV / EBITDA?

United Therapeutics Corp's EV / EBITDA is 14.0×, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Revenue (TTM)?

United Therapeutics Corp's Revenue (TTM) is $3.2B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Net Income (TTM)?

United Therapeutics Corp's Net Income (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's EBITDA?

United Therapeutics Corp's EBITDA is $1.5B, based on as-reported figures from SEC (XBRL) filings.

What is United Therapeutics Corp's Diluted EPS (TTM)?

United Therapeutics Corp's Diluted EPS (TTM) is 30.56, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

United Therapeutics Corp

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S8RV10

549.16▲ 16.38 (3.07%)

As of 2026-10-09

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 532.78
Day's Range: 528.92 – 551.15
52-Week Range: 409.07 – 612.29
Volume: 562.0K
Avg Volume: 761.5K

Share Statistics

Shares Outstanding
Employees: 1,400
Exchange: XNAS
Listed: 1999-06-17

Share count as of July 29, 2026

United Therapeutics Corp (UTHR) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about United Therapeutics Corp (UTHR)

What is United Therapeutics Corp's Market Cap?: United Therapeutics Corp's Market Cap is $23.6B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Enterprise Value?: United Therapeutics Corp's Enterprise Value is $20.9B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Trailing P/E?: United Therapeutics Corp's Trailing P/E is 18.0×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Price / Sales?: United Therapeutics Corp's Price / Sales is 7.5×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EV / Revenue?: United Therapeutics Corp's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EV / EBITDA?: United Therapeutics Corp's EV / EBITDA is 14.0×, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Revenue (TTM)?: United Therapeutics Corp's Revenue (TTM) is $3.2B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Net Income (TTM)?: United Therapeutics Corp's Net Income (TTM) is $1.3B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's EBITDA?: United Therapeutics Corp's EBITDA is $1.5B, based on as-reported figures from SEC (XBRL) filings.
What is United Therapeutics Corp's Diluted EPS (TTM)?: United Therapeutics Corp's Diluted EPS (TTM) is 30.56, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · UTHRAs-filed SEC (XBRL) data